Multiple Sclerosis Therapy for Pediatric Patients Approved by FDA
May 12th 2018Officials with the FDA have approved fingolimod (Gilenya, Novartis) for the treatment of relapsing multiple sclerosis in pediatric patients aged 10 years and older, making it the first FDA-approved drug to treat MS in this population.
Read More